Journal
JOURNAL OF CRITICAL CARE
Volume 23, Issue 1, Pages 18-26Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.jcrc.2008.02.001
Keywords
ventilator-associated pneumonia; ICU outcomes; Psuedomonas aeruginosa
Categories
Ask authors/readers for more resources
Purpose: The aim of this study was to clarify the prevalence and incidence of, risk factors for, and outcomes from suspected ventilator-associated pneumonia (VAP) associated with the isolation of either Pseudomonas or multidrug-resistant (MDR) bacteria (high risk pathogens) from respiratory secretions. Materials and Methods: Data were collected as part of a large, multicentered trial of diagnostic and therapeutic strategies for patients (n = 739) with suspected VAP. Results: At enrollment, 6.4% of patients had Pseudomonas species, and 5.1% of patients had at least 1 MDR organism isolated from respiratory secretions. Over the study period, the incidence of Pseudomonas and MDR organisms was 13.4% and 9.2%, respectively. Independent risk factors for the presence of these pathogens at enrollment were duration of hospital stay >= 48 hours before intensive care unit (ICU) admission (odds ratio, 2.37 [95% CI, 1.40-4.021; P =.001] and prolonged duration of ICU stay before enrollment (odds ratio, 1.50 [95% CI, 1. 17-1.93]; P =.002] per week. Fewer patients whose specimens grew either Pseudomonas or MDR organisms received appropriate empirical antibiotic therapy compared to those without these pathogens (68.5% vs 93.9%, P<.001). The isolation of high risk pathogens from respiratory secretions was associated with higher 28-day (relative risk, 1.59 [95% CI, 1.07-2.37]; P =.04) and hospital mortality (relative risk, 1.48 [95% CI, 1.05-2.07]; P =.05), and longer median duration of mechanical ventilation (12.6 vs 8.7 days, P =.05), ICU length of stay (16.2 vs 12.0 days, P=.05), and hospital length of stay (55.0 vs 41.8 days, P =.05). Conclusions: In this patient population, the incidence of high-risk organisms newly acquired during an ICU stay is low. However, the presence of high risk pathogens is associated with worse clinical outcomes. (c) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available